Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin for slowing growth of small abdominal aortic aneurysms
NL-OMON59514Phase 2Recruiting
- Sponsor
- Uppsala University
- Start
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of metformin in abdominal aortic aneurysm (AAA), sponsored by Uppsala University. Primary endpoint: Change in CT-assessed abdominal aortic aneurysm diameter growth rate. Started Nov 2022; status: recruiting.
02
Drugs
metformin
03
Conditions
abdominal aortic aneurysm (AAA)
Beyond the preview
Go deeper on NL-OMON59514.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON59514.